Interferon beta 1a (IFN-β1a)

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROB
Congenital cataract--0 study
2 non statistically significant endpoints reported in only one study

Growth parameters and prematurity
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROB
Preterm (< 37 weeks)1.16 [0.45, 2.99]63%3 studies249292not evaluable NA

Maternal consequences
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROB
Preeclampsia--0 study
1 non statistically significant endpoints reported in only one study

Neonatal disorders
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROB
1 non statistically significant endpoints reported in only one study

Long term consequences
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROB
Children infections3.75 [1.00, 14.02]-1 study1029not evaluable NA

Intrauterine deaths
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROB
Intrauterine deaths (as a whole or unspecified)0.73 [0.41, 1.31]0%2 studies71292not evaluable NA
1 non statistically significant endpoints reported in only one study